ArcherDX, a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalised genomic medicine has announced that it has entered into a broad strategic collaboration with Genosity
Editor's picks
High performance computing is a field in which engineers often require knowledge of many different areas. An HPC developer must implement a solution to a problem which comes from ‘real’ science, but they also need to understand computer hardware and software.
With new and old companies releasing processors for the HPC market, there are now several options for high-performance server-based CPUs. This is being compounded by setbacks and delays at Intel opening up competition for the HPC CPU market.
News
20 March 2019
Scientific Computing World is searching for scientists and researchers that have found themselves running HPC centres
20 March 2019
Pure has announced a complete portfolio of solutions for AI applications, from early inception to large-scale production
19 March 2019
The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is urging industry stakeholders worldwide to focus on science and not geography, in a call for greater global collaboration
Analysis & opinion
23 August 2018
Today Fujitsu published specifications for the A64FX CPU to be featured in the post-K computer, a future machine designed to be 100 times faster than the legendary K computer that dominated the TOP500 for years
26 April 2018
The best research needs ideas from a wider range of people and publications, writes Anita Schjøll Brede
19 April 2018
Cloud bursting is revolutionising research at universities writes Mahesh Pancholi, Research Computing Specialist at OCF
Features
25 January 2019
Intel’s Cedric Andreolli, Jim Cownie and Kate Antakova explain how the Roofline model can be used to improve HPC code
25 January 2019
Robert Roe reports on the Gordon Bell Prize finalists for 2018, as the list is dominated by AI and deep leaning applications running on the Summit supercomputer
Resources
16 October 2018
04 October 2018
Press Releases
IDBS, a provider of enterprise scientific informatics platforms has announced a new SaaS contract with Genevant Sciences Corporation, a leading biopharmaceutical company focused on the discovery and development of a broad range of RNA-based therapeutics across multiple modalities.
Aldevron, a contract development and manufacturing organisation serving the biotech industry, has announced the release of GMP SpyFi Cas9 Nuclease for clinical and commercial applications
At the 2019 American Physical Society March Meeting, IBM unveiled a new scientific milestone, announcing its highest quantum volume to date
Supercomputer provider Cray has announced that the Board of Directors has elected Stephen Gold as a member of the Board and appointed him to the Strategic Technology Assessment Committee
Super Micro Computer, Inc. (SMCI), a provider of enterprise computing, storage, networking solutions and green computing technology, has announced that the company is launching new Edge systems designed for artificial intelligence (AI) and 5G workloads
Certara, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 19.1 of its flagship scientific informatics platform D360.
D360 v19.1 expands the platform’s capabilities for biologists and biologics scientists, deepens support for small molecule chemistry, and provides workflow enhancements based on community feedback. This latest version of D360 takes its name from its calendar release date; this is the first new release in 2019.
At this week’s Mobile World Congress (MWC) 2019, Intel announced the Intel FPGA Programmable Acceleration Card N3000 (Intel FPGA PAC N3000), designed for service providers to enable 5G next-generation core and virtualised radio access network solutions. The Intel FPGA PAC N3000 accelerates many virtualised workloads ranging from 5G radio access networks to core network applications.
Latest issue
Drug development is facing change – both from technological pressures, such as the use of AI and machine learning, plus new regulations which are driving sweeping changes to the way electronic records are created and stored for clinical trials.
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Scientists are now beginning to use new technologies such as the internet of things (IoT), artificial intelligence (AI) and machine learning (ML) in their daily workflows.
In today’s world, where drug development integrates science and technology, consumer safety is paramount in the pharmaceutical industry.